KMT2A and acute myeloid leukemia: Figure 5A shows that the clonal proliferation of MLL-AF9 transformed cells was suppressed by the compound significantly stronger than the proliferation of normal progenitor cells, consistent with the addiction of AML cells to high levels of MYB activity.